baber/WOPTO huggingface dataset:
Patent PT-904348-E (PT)
Inventor: BRIEDEN WALTER
IPC: C12N1/21
Filed: 1997-05-30
Abstract: Microorganisms (A), or their enzymatic extracts, able to utilise cyclopentene derivatives (VII) as sole carbon (or carbon and nitrogen) source are new. R1 = 1-4C alkyl or alkoxy, or aryl or aryloxy. Also new are (1) N-acetylamino-alcohol hydrolases (NAAH) from (A) able to hydrolyse (VII), and their functionally equivalent variants or mutants; (2) production of (1R,4S) and/or (1S,4R)-1-amino-4-hydroxymethyl-2-cyclopentene (II), or their derivatives N-substituted by COR1, by reacting (VII) with at least one of (A), its enzymatic extract, NAAH and penicillin G acylase.
Patent PT-942729-E (PT)
Inventor: KULAGOWSKI JANUSZ JOZEF
IPC: A61K31/395
Filed: 1997-11-25
Abstract: The present invention provides the use of an orally active, long acting, CNS-penetrant NK-1 receptor antagonist for the manufacture of a medicament adapted for oral administration for the treatment or prevention of stress disorders without concomitant therapy with other anti-stress agents, methods of treatment using such a NK-1 receptor antagonist and pharmaceutical compositions comprising it.
Patent PT-1025121-E (PT)
Title: Peptides capable of inhibiting the interaction between presenilins and the beta-amyloid peptide or its precursor
Inventor: MERCKEN LUC
IPC: G01N33/68
Filed: 1998-10-23
Abstract: A new polypeptide (I) is able to at least partly inhibit the interaction between a presenilin (PS) and a  beta -amyloid peptide ( beta A) and/or its precursor, amyloid precursor protein (APP). Independent claims are also included for the following:  (a) compounds (II) that are not exclusively peptides, with the same activity as (I) obtained by reproducing the active motifs of (I); (b) a nucleic acid (III) encoding (I) or (II);  (c) a recombinant defective virus or vector containing (III); (d) an expression cassette usable in the vector of (c);  (e) a host cell transformed with (III); (f) recombinant production of (I) or (II) by culturing cells of (e); (g) an antibody, or its fragments, directed against peptides (IV; 87 amino acids), (V; 81 amino acids) or fragments of (VI; 695 amino acids) able to inhibit interaction between PS and beta A or APP;  (h) methods for identifying or isolating compounds that can inhibit an interaction between PS and  beta A or APP;  (i) a method for detecting interaction between PS and  beta A or APP by fluorescence transfer between two bound fluorophores; and  (j) ligands of (I), (II), PS,  beta A or APP identified by these methods.
Patent PT-952030-E (PT)
Title: Electric supply circuit for an electric drive system
Inventor: BERND LASKA DR
IPC: B60L9/28
Filed: 1999-04-15
Abstract: The system has a number of drive groups (18), each contains at least one drive motor (M) and an input converter group (12), connected in series to a supply network (UN). Each input converter group is associated with at least one transformer group (14) which supplies the group's drive motors from the secondary sides via a drive converter. Each input converter group is also associated with at least one compensation circuit (20) which manages a uniform load distribution at the input converter groups by connecting the inputs of the drive converter together electrically. Preferably, the compensation circuit provides an actuator for each drive converter coupled to the compensation circuit at the input side. The actuators feed parallely on a secondary DC intermediate circuit (34).
Patent PT-1048216-E (PT)
Inventor: REIMERDES ERNST H
IPC: A23C9/18
Filed: 1999-04-28
Abstract: The present invention concerns a dry milk product comprising milk particles, which is densified, containing between 0 and 50 % fat, having a loose density comprised between 0.40 and 0.80 g/ml, a porosity comprised between 0.35 and 0.65 and being densified at a densification degree comprised between 40 and 70 %.
Patent PT-1109962-E (PT)
Inventor: REASON ANDREW MARTIN
IPC: D06F39/14
Filed: 1999-09-06
Abstract: An apparatus comprising an outer casing with a base, at least one side wall, and a top, within which are located a drum, typically with a curved side wall and first and second end walls, an agitator and a liquid retainer. The liquid retainer and a side wall having aligned ports through which an end portion of the drum may reversibly travel between a first retracted position and a second extended position. The travel of the drum out of the side wall to the extended position allows access to at least one aperture in the curved side wall of the drum.
Patent SG-22290-G (SG)
Title: Process for the preparation of ferrierite and its use as dewaxing catalyst(carrier)
IPC: C10G45/64
Filed: 1990-03-20
Abstract: Process for the preparation of ferrierite which comprises maintaining an aqueous starting mixture containing at least one silicon compound, at least one aluminium compound, at least one alkali metal (M) compound and at least one organic nitrogen compound (RN) selected from the group consisting of piperidine, pyridine, allyl-substituted piperidines and -pyridines, piperazine, 4-picoline and 4-picoline-N-oxide, at an elevated temperature until crystalline ferrierite has formed, in which starting mixture the various compounds are present in the following molar ratios, the aluminium-, silicon- and alkali metal-compounds being calculated on basis of the oxides:      SiO2 : M2O = 7.3 to 15.6,      SiO2 : Al2O3 = 15.6 to 35.7,      H2O : SiO2 = 5 to 500, and      RN : SiO2 = 0.05 to 1.0. The ferrierite catalyst precursor thus prepared can after conversion into the hydrogen form be used as catalyst (carrier) for dewaxing hydrocarbon oils (e.g. lubricating base oils).
Patent IE-37134-L (IE)
Title: Antibacterial compositions
IPC: A61K31/42
Filed: 1973-01-23
Abstract: 1421023 Antibacterial compositions MERCK & CO Inc 29 Jan 1973 [3 Feb 1972 13 Dec 1972] 4426/73 Heading A5B Antibacterial compositions comprise as active ingredients a mixture of 3-fluoro-D-alanine, a deuterated 3-fluoro-D-alanine, or a pharmacologically acceptable salt or ester thereof with an autoantagonist inhibitor, which is a compound that has the ability, or that is converted in aqueous media to a compound having the ability, to inhibit the action of the D-alanyl-D-alanine synthetase and/or D-alanine; α-ketoglutarate transaminase enzymes of microorganisms, e.g. D-cycloserine, 1, 4-bis-(3- oxoisoxazolidin-4-yliminomethyl) benzene, D- (cis or trans)-4-amino-5-methylisoxazolidin-3- one and compounds that in vivo or in solution in an aqueous medium liberate D-cycloserine, D-(cis or trans)-4-amino-5-methylisoxazolidin- 3-one. The 3-fluoro-D-alanine component may be 3-fluoro-D-alanine, 2-deutero-3-fluoro-D-alanine, 2, 3-dideutero-3-fluoro-D-alanine, 2, 3, 3- trideutero-3-fluoro - D - alanine, a C 1-5 alkyl ester thereof such as the methyl ester, or a pharmacologically acceptable salt such as the sodium, calcium or hydrochloride salt. The compositions may be administered orally or parenterally in the form of capsules, tablets, solutions or suspensions.
[GB1421023A]
Patent IE-900182-L (IE)
Title: A method of rapidly controlling the frequency of a coherent¹radio receiver and apparatus for carrying out the method
IPC: H04L27/18
Filed: 1990-01-17
Abstract: The invention relates to a method and to an arrangement for rapidly controlling the frequency of a radio-receiver which receives signal-sequences which have been subjected to interference and which include a synchronizing-sequence and a data sequence. The signal-sequence is converted in an A/D-converter to provide signal-points (ET) which are intended for analysis, and a Viterbi-algorithm (10) is adapted (12,13) with the aid of adaptation signals (U1) obtained from the synchronizing-sequence of the prevailing interferences. The data-sequence is Viterbi-analyzed through a large number of calculating stages, for the purpose of determining the bit-sequence (S1) of the data-sequence. According to the invention the signal-point (ET) is branched-up to branch-signal points (ET), the number of which is equal to the number of states of the Viterbi-algorithm (10). Each individual branch-signal point is phase-shifted (20) to a corrected signal-point (ET,1) and is compared (21) with its adaptation signal (U1), which has separate (K) signal points. Distances ( DELTA ST,1) and angular deviations ( DELTA phi T,1) are calculated between the corrected signal-point (ET,1) and the adaptation-signal (U1) signal points. A transition (K<1>) is selected through the Viterbi-algorithm (10), with the aid of the distances ( DELTA ST,1) and the angular deviation ( DELTA phi T,1,) corresponding thereto is selected (22). Selected angular deviations ( DELTA phi T,1) for successive incoming signal-points (ET) are low-pass filtered and integrated (22) to form a phase correction signal (V) through which the phase of the successively incoming branch-signal points (ET) are shifted (20). Corresponding phase correction signals are calculated for the remaining states of the Viterbi-algorithm (10).
Patent IE-44366-L (IE)
Title: Ball and socket joint
IPC: F16C11/08
Filed: 1977-02-18
Abstract: An improved ball and socket joint usable in a steering system includes a stud having an enlarged head or ball portion and a socket having a cavity closed by an end cap, the socket cavity being adapted to receive the stud head therein. An expander, such as a belleville spring, is resiliently compressed between the end cap and the head. The expander is the sole item interposed between the end cap and the head and serves the dual role of expander and supplemental seat for the head. The expander has a center opening, through which the head directly contacts the end cap and is pre-loaded by it. As the assembly sustains wear, the expander comes into play to maintain loading on the head and to keep the head seated on the expander. Problems of tolerance stackup are avoided by preloading the end cap directly by the head, and utilizing the expander as the supplemental seating means. By initially compressing the expander to a fully flattened state, travel of the expander to full relaxation is available to take up wear.
[US4035094A]
Patent IE-820430-L (IE)
Title: Amorphous metal alloys
IPC: C22C33/00
Filed: 1982-02-26
Abstract: A process for producing iron, phosphorus, carbon and chromium based amorphous metal alloys of the type in which a metal alloy in the liquid phase is cooled very rapidly to obtain a vitreous structure, wherein the liquid phase is prepared from cast iron, phosphorus and chromium. This process provides a low cost amorphous alloy as compared to that of crystalline products, and one which, however, possesses improved properties. The invention also relates to the amorphous alloy obtained having the following composition by atomic percentage: Cr: 1.5 to 8; C: 8 to 16; P: 4 to 12; Si: up to 3.5; the remainder being iron and the P/C ratio being less than 1.
[US4400208A]
Patent IE-42316-L (IE)
Title: Apparatus for cutting ensilaged material
IPC: A01F25/20
Filed: 1976-03-05
Abstract: An apparatus capable of detaching from a body of a material such as hay a portion thereof which then can be transported to a desired location. A prime mover such as a tractor carries at one of its ends, for example, a frame which supports a cutting structure capable of cutting into a body of a material such as hay in such a way as to carry out a slicing action while cutting into the body, so as to detach from the body a portion thereof which then can be transported to a desired location.
[US4058038A]
Patent IE-44948-L (IE)
Title: Thiazolo (and thiadiazolo) pyrimidines
IPC: A61K31/38
Filed: 1977-05-11
Abstract: Substituted 7H-thiazolo- and 7H-thiadiazolo-pyrimidine-7-ones compounds and the drug composition containing same. The compounds are immunostimulants for mammals. A process of making these compounds and of using the drug composition.
[US4237136A]
Patent FI-820632-L (FI)
Inventor: STAHLHOFEN PAUL
IPC: G03C1/60
Filed: 1982-02-24
Abstract: A light-sensitive mixture, which is composed of a light-sensitive compound, for example, an o-quinone-diazide or a diazonium salt polycondensate, or a light-sensitive combination of compounds, for example, a photolytic acid donor and an acetal compound or orthocarboxylic acid compound which can be cleaved by acid, and of a novolak having halogenated phenol units is described. The mixture is preferably used for the preparation of printing plates, in particular planographic printing plates, which have an improved resistance to aqueous-alkaline developer solutions, gasoline hydrocarbons and fountain solutions containing alcohol.
Patent FI-824356-L (FI)
Inventor: HARTWIG CARL SVERKER MAGNUSSON
IPC: H02P6/00
Filed: 1982-12-17
Abstract: A compressor drive system for controlling the gas pressure in a pressure gas volume (106) connected to the compressor (101). A brushless alternating current motor (23) is directly coupled to the compressor, which is driven with the same speed as the motor. The pressure in the gas volume (106) is sensed by pressure sensing means (109) connected to a converter (114). The converter simultaneously changes the amplitude and frequency of the drive voltage supplied to the motor (23). This is done in response to pressure changes in volume (106). The motor is stopped if the pressure exceeds a preset maximum value. A pressure gas container (104) is depressurized at motor stop to allow restarting without counter pressure on the compressor. Means (44) for controlling the amplitude and frequency of the drive voltage is provided so that the normal speed maximum load current is never exceeded during motor start.
Patent FI-831412-L (FI)
Inventor: NARR BERTHOLD
IPC: C07D265/18
Filed: 1983-04-26
Abstract: This invention is directed to novel benzoxazin-2-ones of the formula <IMAGE>  (I)  wherein A is a sulfur atom or an SO, SO2, R-N=S, or R-N=SO2 group where R is a hydrogen atom or an acyl group; D is an alkylene group; R1 is an alkyl, phenylalkyl, cycloalkyl, or phenyl group; R4 is a hydrogen atom or an alkyl group; R5 is a hydrogen or halogen atom or a nitro or alkyl group; and R6 is a hydrogen or halogen atom or an alkyl group, having valuable pharmacological properties, particularly an antithrombotic activity. The compounds of Formula I may be prepared by the methods used for analogous compounds.
Patent FI-844373-L (FI)
Inventor: FLESHER PETER
IPC: C08F6/20
Filed: 1984-11-07
Abstract: An aqueous sizing composition can be prepared by mixing into water a concentrate that comprises a substantially anhydrous dispersion of a polyelectrolyte in an organic liquid comprising a solution of a reactive size in a hydrophobic solvent.
Patent IE-881085-L (IE)
Title: Thiophene derivatives
IPC: C07D409/14
Filed: 1988-04-11
Abstract: Compounds of the following formula have pharmaceutical properties: <CHEM> in which R<1> and R<2> independently are hydrogen, halo, nitro, amino, C2-5 acylamino, C1-4 alkyl, C1-4 alkoxy, C1-4 alkylthio, C1-4 alkylsulphonyl, N-substituted heterocyclyl, optionally substituted phenyl, optionally substituted phenylthio, optionally substituted phenylsulphonyl or optionally substituted phenylsulphonamido, or R<1> and R<2> together form a C3-5 alkylene bridge, R<3> is C1-4 alkyl or C2-4 alkenyl, and X is (i) -(CH2)nN(R<4>)2 where each R<4> independently is C1-4 alkyl, C2-4 alkenyl or optionally substituted C6H5CH2-, and n is 1, 2 or 3, or (ii) a 5- to 8-membered alicyclic group containing one or two nitrogen atoms and directly attached to the amido nitrogen or attached by a C1-3 alkylene chain; and salts thereof.
[EP0297697A1]
Patent IE-861127-L (IE)
Title: Condensed oxygen heterocyclics
IPC: A61K31/343
Filed: 1986-04-29
Abstract: Compounds are described of formula (II) <IMAGE> (II) and salts thereof, wherein R1 reprsents a methyl, ethyl or isopropyl group; R2 represents a hydrogen atom or a group OR5 (where OR5 is a hydroxy group or a substituted hydroxyl group having up to 25 carbon atoms) and R3 represents a hydrogen atom, or R2 and R3 together with the carbon atom to which they are attached represent a >C=0 group; and OR4 represnts a group OR5 as defined above; with the proviso that when R2 represents a hydroxy group OR4 represents a substituted hydroxy group other than a methoxy group. These compounds may be used for controlling insect, acarine, nematide or other pests.
[US4978675A]
Patent IE-871586-L (IE)
Title: 4(3H)-OXO-5,6,7,8-TETRAHYDROPYRIDO (2,3-d) PYRIMIDINES
IPC: A61P35/00
Filed: 1987-06-15
Abstract: The invention pertains to derivatives of N-[4-(N-[2-amino-4(3H)-oxo-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-6- ylmethyl]a mino)benzoyl]-L-glutamic acid of the formula: <CHEM> wherein R<1> is hydrogen, methyl, ethyl, or R<5>CO-; R<2'> and R<3'> are hydrogen or a carboxylic acid protecting group; R<4'> is hydrogen or an amino protecting group; and R<5> is hydrogen or alkyl and the configuration about the carbon atom designated * is L, which derivatives are antineoplastic agents, to their preparation and use, and to intermediates useful in their preparation.
[EP0255228A1]
Patent IE-41502-L (IE)
Title: Dustless feed premix containing a quinoxaline-1, 4-dioxide
IPC: A23K1/16
Filed: 1975-08-20
Abstract: 1504029 Dustless animal feeds containing Quinoxaline - 1, 4 - Dioxide PFIZER INC 11 Sept 1975 [23 Sept 1974] 37481/75 Heading A5B [Also in Division A2] A dustless animal feed supplement premix containing anti bacterial quinoxaline - 1, 4 - dioxide processed by (a) blending 0.5 - 2.0 wt.% of a non - toxic oil with 80-95wt.% of an edible carrier (b) mixing the blend from (a) with 2-12wt.% of a pharmaceutically acceptable-quinoxaline - 1, 4 - dioxide anti-bacterial agent (c) blending the mixture from (b) with 0.75-6.0wt.% of the said oil such that the total amount of oil added is from 1.25-8wt.% (wt. percentages are expressed in terms of the total weight of the supplement premix product). Oils may be selected from soybean, corn or mineral oils and edible carrier from soybean mill run, rice brans, soybean mill, soybean grits, rapeseed meal, corn meal, corn germ meal, corn gluten feed wheat middlings, soft phosphate rock or mixtures thereof with silicon dioxide or calcium carbonate.
[GB1504029A]
Patent IE-891814-L (IE)
Title: Amblyommin, for use in anticoagulant therapy
IPC: A61P7/02
Filed: 1989-06-12
Abstract: The invention relates to a new active substance-amblyommin-for anticoagulant therapy and to a process for the isolation thereof from hard ticks. The isolated protein having a thrombin-inhibitory action has a molecular weight of 20000 to 30000 dalton, an isoelectric point between 5.05 and 5.65 and the partial amino acid sequences Ile-Leu-Phe-Thr-Gln-Gly-Asn-X-Gly-Glu-Leu-Glu-Asn-X-Phe-Glu-, Lys-Ile-Leu-Phe-X-Gln-Gly- and Ala-Ser-Tyr-Ile-Val-X-Ser-Glu-Ser-Ile-Gln-Ile-Leu-X-Leu-Ser-Glu-Gly-Ile- in which each radical X can be identical or different and each represents a naturally occurring amino acid.
Patent IE-872147-L (IE)
Title: a road cone
IPC: E01F9/012
Filed: 1987-08-11
Abstract: A traffic hazard indicator device comprises a base (11) and a member (12) supported by the base; the member being cone or pyramid shaped; the member having a recess thereon (16) which is adapted to receive and retain therein an element having a reflective and/or different colour characteristics to that of the member. The member is preferably pyramid shaped and the recesses are preferably trapezoidal. <IMAGE>
[GB2207943A]
Patent IE-802207-L (IE)
Title: Curing of meat
IPC: A23B4/023
Filed: 1980-10-24
Abstract: A method of curing meat products is disclosed in which residual nitrite levels. In this method the fresh meat in particular pork bellies is contacted with a stable curing solution comprising an alkali metal hexametaphosphate, an alkali metal chloride, a soluble nitric oxide forming compound and an alkalizing agent, said curing solution providing an average pH of the meat being cured about equivalent to the natural pH of the meat. In a particular case cured bacon having low residual nitrite levels is prepared by contacting pork bellies with an aqueous curing solution comprising from 10% to 20% sodium chlobride. from 0.05% to 0.15% soluble nitric oxide forming composition. and from 2.0% to 4.5% of a composition selected from A) from 93% to 97% sodium hexametaphosphate, and from 3% to 7% sodium bicarbonate, and, B) from 75% to 85% sodium hexametaphosphate, from 7% to 13% sodium acid pyrophosphate. and from 7% to 13% sodium bicarbonate. The percentages relative to the curing solution being by weight based on the total weight of the aqueous solution, the percentages under subsections A) and B) totalling substantially 100% based on the weight of the components recited in these subsections. Composition A) constitutes a novel stable meat curing solution additive.
[EP0028113A2]
Patent IE-39038-L (IE)
Title: Lifting apparatus for submerged pipeline
IPC: B66C1/42
Filed: 1973-12-10
Abstract: Tong apparatus operated oleopneumatically for lifting a submerged pipeline either directly by a frogman or by an operator on a pontoon or vessel. The apparatus includes a pair of jaws controlled by a double acting cylinder with two pistons. The cylinder has a body pivotally connected to the upper end of one jaw and has an active chamber wherein a first piston with a wide cross-section slides, while a second piston having a small cross-section is pivotally connected to the upper end of the other jaw and slides coaxially as to the first piston in a second active chamber provided by the wide cross-section of the said first piston.
[US3897099A]
Patent IE-802471-L (IE)
Title: Prostanoic acid derivatives.
IPC: C07C59/76
Filed: 1980-11-27
Abstract: 4,5-Unsaturated 16-hydroxy prostanoic acid derivatives displaying valuable pharmacological properties, e.g. gastric antisecretory, are described herein.
[US4271314A]
Patent NO-824420-L (NO)
Inventor: ZIMMERMANN MARKUS
IPC: C07D491/048
Filed: 1982-12-30
Abstract: The present invention relates to novel N-oxide compounds that have cardiovascular properties, especially antihypertensive activity, and that correspond to the formula    <IMAGE>  (I)  in which Py represents an unsubstituted or substituted N-oxidopyridyl radical, R1 represents hydrogen or unsubstituted or substituted lower alkyl, one of the radicals R2 and R3 represents lower alkyl and the other represents hydrogen; lower alkyl; lower alkyl containing free, etherified or esterified hydroxy, oxo, functionally modified carboxy or free or substituted amino or imino; functionally modified carboxy; or free or substituted amino, it being possible for an amino group R2 or R3 to be bonded to a lower alkyl radical R1 or, if R2 or R3 represents, for example, hydroxy-lower alkyl, for this hydroxy-lower alkyl, together with the adjacent acyl radical Ac1 or Ac2, to form a 2-oxa-1-oxo-lower alkylene radical, the carbonyl group of which is bonded to the 3- or 5-ring carbon atom of the 1,4-dihydropyridine ring, and each of the groups Ac1 and Ac2  represents, independently of the other, the acyl radical of an acid, and salts of compounds of the formula I having salt-forming groups, processes for the manufacture of these compounds, the use of these compounds and their salts, and pharmaceutical preparations which contain these compounds and salts, as antihypertensive agents and coronary dilators for the treatment of cardiovascular conditions, such as hypertonia, vascular constrictions, Angina pectoris and cardiac insufficiency.
Patent NO-832861-L (NO)
Title: Tiltrekningsmiddel for hann-moell
Inventor: SZANTAY CSABA
IPC: A01N37/02
Filed: 1983-08-09
Abstract: Oppfinnelsen angår et sammensatt insekt-tiltrekningsmiddel for hanner av hvetesommerfugl (Scotia segetum),at det inneholder en kombinasjon bestående av 1-98 vekt% 5(Z)-decen-l-ol-. acetat med formelen (I),. 1-98 vekt* 7(Z)-dodecen-l-ol-acetat med formel (II):og 1-98 vekt% 9(Z)-tetradecen-l-ol-acetat med formel (III) :. som aktiv bestanddel, eventuelt sammen med et flytende eller fast hjelpemiddel. Oppfinnelsen angår også en insektfelle inneholdende ovennevnte preparat. Oppfinnelsen angår også en fremgangsmåte for å tiltrekke og fange hvetesommerfugler såvel som en fremgangsmåte for å forstyrre deres parring ved en luftbehandlings-metode.Preparatet og insektfellen i henhold til oppfinnelsen kan anvendes med fordel for plantebeskyttelse.